Research Progress on a SARS-CoV-2 Vaccine in China

Although many countries have controlled the pandemic of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) through strict management, there are still with record-breaking numbers new cases. Therefore, it is very important to develop a vaccine that can cause wide cross reactivity in clinical trials. At present, more than 90 vaccines entering trials and progressing smoothly, including inactivated vaccines, adenovirus-vectored other types vaccines. Here, we review summarize efficacy potential threats SARS-CoV-2 vaccine. We reviewed whole-virus adenovirus-subunit recombinant protein discussed positive negative consequences However, heated debates on mechanism, effectiveness, breadth protection. In conclusion, this study predict risk outbreaks future by discussing research development status China countries. Looking future, mine large amount data generated universal ensure these programs equally useful face mutations.